Creating Hope Reauthorization Act
USA116th CongressHR-4439| House
| Updated: 9/30/2020
G. K. Butterfield
Democratic Representative
North Carolina
Cosponsors (42)
Mo Brooks (Republican)Roger Marshall (Republican)Markwayne Mullin (Republican)Mikie Sherrill (Democratic)Robin L. Kelly (Democratic)Tom Malinowski (Democratic)Lisa Blunt Rochester (Democratic)Jackie Speier (Democratic)Darren Soto (Democratic)Eliot L. Engel (Democratic)Bobby L. Rush (Democratic)Steve Cohen (Democratic)Tony Cárdenas (Democratic)Earl L. "Buddy" Carter (Republican)Peter A. DeFazio (Democratic)A. Donald McEachin (Democratic)Kenny Marchant (Republican)Ann M. Kuster (Democratic)Gus M. Bilirakis (Republican)H. Morgan Griffith (Republican)André Carson (Democratic)Mark DeSaulnier (Democratic)Joe Wilson (Republican)Steve King (Republican)Elaine G. Luria (Democratic)Rodney Davis (Republican)Mike Kelly (Republican)Richard Hudson (Republican)John H. Rutherford (Republican)Rob Woodall (Republican)Michael T. McCaul (Republican)Diana DeGette (Democratic)Debbie Lesko (Republican)Jeff Fortenberry (Republican)Yvette D. Clarke (Democratic)Brian K. Fitzpatrick (Republican)Suzanne Bonamici (Democratic)Zoe Lofgren (Democratic)Nanette Diaz Barragán (Democratic)Cathy McMorris Rodgers (Republican)Troy Balderson (Republican)Katie Porter (Democratic)
Health Subcommittee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Creating Hope Reauthorization Act This bill reauthorizes a Food and Drug Administration (FDA) program that awards priority review vouchers to manufacturers of drugs that treat rare pediatric diseases. (A priority review voucher entitles the voucher holder to priority review of a single human drug application.) Specifically, the bill reauthorizes the program through FY2024, but the FDA may award a voucher afterwards in certain instances.
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Committee Consideration and Mark-up Session Held.
Ordered to be Reported (Amended) by Voice Vote.
Placed on the Union Calendar, Calendar No. 451.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-551.
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Considered under suspension of the rules. (consideration: CR H5023-5025)
DEBATE - The House proceeded with forty minutes of debate on H.R. 4439.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5023)
Motion to reconsider laid on the table Agreed to without objection.
The title of the measure was amended. Agreed to without objection.
Received in the Senate.
Health
Child healthDrug safety, medical device, and laboratory regulationHealth programs administration and fundingHealth promotion and preventive careInfectious and parasitic diseases
Creating Hope Reauthorization Act
USA116th CongressHR-4439| House
| Updated: 9/30/2020
Creating Hope Reauthorization Act This bill reauthorizes a Food and Drug Administration (FDA) program that awards priority review vouchers to manufacturers of drugs that treat rare pediatric diseases. (A priority review voucher entitles the voucher holder to priority review of a single human drug application.) Specifically, the bill reauthorizes the program through FY2024, but the FDA may award a voucher afterwards in certain instances.
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Committee Consideration and Mark-up Session Held.
Ordered to be Reported (Amended) by Voice Vote.
Placed on the Union Calendar, Calendar No. 451.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-551.
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Considered under suspension of the rules. (consideration: CR H5023-5025)
DEBATE - The House proceeded with forty minutes of debate on H.R. 4439.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5023)
Motion to reconsider laid on the table Agreed to without objection.
The title of the measure was amended. Agreed to without objection.
Received in the Senate.
G. K. Butterfield
Democratic Representative
North Carolina
Cosponsors (42)
Mo Brooks (Republican)Roger Marshall (Republican)Markwayne Mullin (Republican)Mikie Sherrill (Democratic)Robin L. Kelly (Democratic)Tom Malinowski (Democratic)Lisa Blunt Rochester (Democratic)Jackie Speier (Democratic)Darren Soto (Democratic)Eliot L. Engel (Democratic)Bobby L. Rush (Democratic)Steve Cohen (Democratic)Tony Cárdenas (Democratic)Earl L. "Buddy" Carter (Republican)Peter A. DeFazio (Democratic)A. Donald McEachin (Democratic)Kenny Marchant (Republican)Ann M. Kuster (Democratic)Gus M. Bilirakis (Republican)H. Morgan Griffith (Republican)André Carson (Democratic)Mark DeSaulnier (Democratic)Joe Wilson (Republican)Steve King (Republican)Elaine G. Luria (Democratic)Rodney Davis (Republican)Mike Kelly (Republican)Richard Hudson (Republican)John H. Rutherford (Republican)Rob Woodall (Republican)Michael T. McCaul (Republican)Diana DeGette (Democratic)Debbie Lesko (Republican)Jeff Fortenberry (Republican)Yvette D. Clarke (Democratic)Brian K. Fitzpatrick (Republican)Suzanne Bonamici (Democratic)Zoe Lofgren (Democratic)Nanette Diaz Barragán (Democratic)Cathy McMorris Rodgers (Republican)Troy Balderson (Republican)Katie Porter (Democratic)
Health Subcommittee, Energy and Commerce Committee
Health
Related Bills
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Child healthDrug safety, medical device, and laboratory regulationHealth programs administration and fundingHealth promotion and preventive careInfectious and parasitic diseases